Advances in therapies for neurological lysosomal storage disorders

S Ellison, H Parker, B Bigger - Journal of Inherited Metabolic …, 2023 - Wiley Online Library
Abstract Lysosomal Storage Disorders (LSDs) are a diverse group of inherited, monogenic
diseases caused by functional defects in specific lysosomal proteins. The lysosome is a …

Gene therapy developments for Pompe disease

Z Unnisa, JK Yoon, JW Schindler, C Mason, NP van Til - Biomedicines, 2022 - mdpi.com
Pompe disease is an inherited neuromuscular disorder caused by deficiency of the
lysosomal enzyme acid alpha-glucosidase (GAA). The most severe form is infantile-onset …

Neuromuscular Development and Disease: Learning From in vitro and in vivo Models

Z Fralish, EM Lotz, T Chavez, A Khodabukus… - Frontiers in cell and …, 2021 - frontiersin.org
The neuromuscular junction (NMJ) is a specialized cholinergic synaptic interface between a
motor neuron and a skeletal muscle fiber that translates presynaptic electrical impulses into …

Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing

T Fleury Curado, H Pho, C Freire… - American journal of …, 2021 - atsjournals.org
Rationale: Obstructive sleep apnea is recurrent upper airway obstruction caused by a loss of
upper airway muscle tone during sleep. The main goal of our study was to determine if …

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

A Tarallo, C Damiano, S Strollo, N Minopoli… - EMBO Molecular …, 2021 - embopress.org
Pompe disease is a metabolic myopathy due to acid alpha‐glucosidase deficiency. In
addition to glycogen storage, secondary dysregulation of cellular functions, such as …

Current avenues of gene therapy in Pompe disease

C Leon-Astudillo, PD Trivedi, RC Sun… - Current Opinion in …, 2023 - journals.lww.com
Gene therapy for the treatment of patients with Pompe disease is feasible and offers an
opportunity to fully correct the principal pathology leading to cellular glycogen accumulation …

Chemogenetic activation of hypoglossal motoneurons in a mouse model of Pompe disease

ML Singer, S Rana, ES Benevides… - Journal of …, 2022 - journals.physiology.org
Pompe disease is a lysosomal storage disease resulting from absence or deficiency of acid
α-glucosidase (GAA). Tongue-related disorders including dysarthria, dysphagia, and …

The respiratory phenotype of Pompe disease mouse models

AF Fusco, AL McCall, JS Dhindsa, L Zheng… - International Journal of …, 2020 - mdpi.com
Pompe disease is a glycogen storage disease caused by a deficiency in acid α-glucosidase
(GAA), a hydrolase necessary for the degradation of lysosomal glycogen. This deficiency in …

Gene delivery to the hypoglossal motor system: preclinical studies and translational potential

BM Doyle, ML Singer, T Fleury-Curado, S Rana… - Gene therapy, 2021 - nature.com
Dysfunction and/or reduced activity in the tongue muscles contributes to conditions such as
dysphagia, dysarthria, and sleep disordered breathing. Current treatments are often …

Optogenetic activation of the tongue in spontaneously breathing mice

ML Singer, ES Benevides, S Rana… - Respiratory physiology …, 2023 - Elsevier
Inadequate tongue muscle activation contributes to dysarthria, dysphagia, and obstructive
sleep apnea. Thus, treatments which increase tongue muscle activity have potential clinical …